Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Extension Study of the Effects of LMTM in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)

NCT02245568 is registered in ClinicalTrials.gov with TauRx Therapeutics Ltd as lead sponsor.

NCT NCT02245568
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02245568 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Extension Study of the Effects of LMTM in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Lead sponsor
TauRx Therapeutics Ltd
Phase
Phase 3
Overall status
Terminated
Start date
August 31, 2014
Completion date
May 31, 2017
Enrollment
913 (actual)
Sites
135

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, behavioral variant frontotemporal dementia